Bausch + Lomb (BLCO) stock forecast for 2022. Forecast tables and graphs.

Bausch + Lomb (BLCO) stock forecast for 2022

Last update: December 3, 2022 (08:02)

Sector: Healthcare

The share price of Bausch + Lomb Corporation (BLCO) now

What analysts predict: $29.68

52-week high/low: $20.2 / $12.2

50/200 Day Moving Average: $15.12 / $15.7

This figure corresponds to the average price over the previous 50/200 days. For Bausch + Lomb stocks, the 50-day moving average is the support level today.

For Bausch + Lomb stocks, the 200-day moving average is the resistance level today.

Are you interested in Bausch + Lomb stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bausch + Lomb stock price in 2022. How much will one Bausch + Lomb share be worth in 2022?

Is it worth taking profit / loss on Bausch + Lomb stock now or waiting? What are analysts' forecasts for Bausch + Lomb stock?

We forecast Bausch + Lomb stock performance using neural networks based on historical data on Bausch + Lomb stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Bausch + Lomb stock prediction results are shown below and presented as a graph, table and text information.

Bausch + Lomb stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Bausch + Lomb analysts is $29.68.

Today 200 Day Moving Average is the resistance level (15.7 $).

50 Day Moving Average is the support level (15.12 $).





Historical and forecast chart of Bausch + Lomb stock

The chart below shows the historical price of Bausch + Lomb stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bausch + Lomb stock price can be found in the table below.

Bausch + Lomb (BLCO) Forecast for 2022

Month Target Pes. Opt. Vol., %

Bausch + Lomb information and performance

Bausch + Lomb is the eye health company dedicated to Bringing Visionary Ideas to Eye Health. They offer the world most comprehensive portfolio of eye health products, and They have one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with approximately 13,000 employees worldwide, and with products available in more than 100 countries.

Bausch + Lomb Address

520 APPLEWOOD CRESCENT, VAUGHAN, ON, CA

Market Capitalization: 5 453 502 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 647 000 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 96.81

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.572

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.16

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.886

Quarterly Revenue Growth YOY: -0.007

Trailing PE: 96.81

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 22.52

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.96

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.97

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 350001000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Bausch + Lomb price target for 2022 by month




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.